[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100616750":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":10,"centralContacts":23,"locations":33,"responsibleParty":47,"collaborators":49,"id":52,"slug":53,"hasResults":54,"nctId":55,"briefTitle":56,"officialTitle":56,"acronym":10,"eligibilityCriteria":57,"healthyVolunteers":54,"sex":58,"minAge":59,"maxAge":10,"enrollmentInfo":60,"targetDuration":10,"studyType":63,"phases":10,"briefSummary":64,"conditions":65,"keywords":67,"overallStatus":72,"whyStopped":10,"lastUpdateSubmitDate":73,"lastUpdatePostDateStruct":74,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":82},{"fullName":5,"class":6},"Xuanwu Hospital, Beijing","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"OH Group",null,"This study enrolls patients diagnosed with orthostatic hypotension (OH). Participants must have one of the following underlying conditions: 1) clinically established or probable Parkinson's disease; 2) clinically diagnosed multiple system atrophy; or 3) diabetes mellitus and aged ≥50 years. All participants in this group must meet the standard diagnostic criteria for OH (a decrease in systolic blood pressure of ≥20 mmHg or a decrease in diastolic blood pressure of ≥10 mmHg within 3 minutes of standing).",[13],"Other: Intelligent diagnostic system for orthostatic hypotension",{"label":15,"type":10,"description":16,"interventionNames":17},"Non-OH Control Group","This study also enrolls a control group of patients without orthostatic hypotension (OH). Control participants must have the same underlying diseases as the OH group (Parkinson's disease, multiple system atrophy, or diabetes mellitus aged ≥50 years) but do not meet the diagnostic criteria for OH during the active standing test. This group is used for comparison with the OH group regarding cerebrovascular hemodynamic parameters and clinical outcomes.",[13],[19],{"type":6,"name":20,"description":21,"armGroupLabels":22,"otherNames":10},"Intelligent diagnostic system for orthostatic hypotension","All participants will undergo a standardized multi-parameter monitoring protocol. After resting in the supine position for at least 10 minutes, participants will perform an active standing test. During this protocol, the following parameters are continuously and synchronously recorded using the integrated intelligent diagnostic system: non-invasive beat-to-beat blood pressure, cerebral blood flow velocity in the middle cerebral artery (assessed via transcranial Doppler, TCD), electrocardiogram (ECG), and end-tidal carbon dioxide (ETCO₂). Monitoring is conducted for a 10-minute baseline period in the supine position and continues for up to 10 minutes following standing.",[15,9],[24,29],{"name":25,"role":26,"phone":27,"phoneExt":10,"email":28},"Yingqi Xing","CONTACT","+8618610047846","xingyq2009@sina.com",{"name":30,"role":26,"phone":31,"phoneExt":10,"email":32},"Yihong Gu","+8618681333508","947061118@qq.com",[34],{"facility":35,"status":10,"city":36,"state":37,"zip":38,"country":39,"countryCode":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":10},"Xuanwu Hospital, Capital Medical University","Beijing","Beijing Municipality","100053","China","CN",{"type":42,"coordinates":43},"Point",[44,45],116.39723,39.9075,{"lat":45,"lon":44},{"type":48,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[50],{"name":51,"class":6},"The First Hospital of Jilin University","100616750","research-development-and-application-of-intelligent-diagnostic-system-for-orthostatic-hypotension-100616750",false,"NCT07309666","Research, Development, and Application of Intelligent Diagnostic System for Orthostatic Hypotension","Inclusion Criteria:\n\n1. Adult patients (≥18 years old).\n2. Clinical diagnosis of Parkinson's disease (PD) OR multiple system atrophy (MSA) OR diabetes mellitus (if diabetic, must be aged ≥50 years).\n3. Suspected or diagnosed with orthostatic hypotension (OH).\n4. Presence of adequate acoustic temporal bone windows for Transcranial Doppler (TCD) monitoring.\n5. Willing and able to provide informed consent.\n\nExclusion Criteria:\n\n1. Significant intracranial or extracranial arterial stenosis (≥70% confirmed by ultrasound).\n2. Recent stroke or intracerebral hemorrhage (confirmed by CT\u002FMRI).\n3. Severe cardiac arrhythmias (e.g., atrial fibrillation) or severe valvular heart disease.\n4. Bilateral temporal bone windows insufficient for TCD monitoring.\n5. Pregnancy or lactation.\n6. Inability to cooperate with the testing procedures.\n7. Other systemic diseases that significantly affect cerebral blood flow regulation (e.g., severe thyroid or renal dysfunction).","ALL","18 Years",{"count":61,"type":62},2000,"ESTIMATED","OBSERVATIONAL","Orthostatic hypotension (OH) has a high incidence rate of 30%-50% in the elderly and populations with neurodegenerative diseases. The resulting cerebral hypoperfusion significantly increases the risk of cerebral ischemia, falls, and cognitive decline. Traditional OH diagnosis primarily relies on intermittent cuff blood pressure measurements, leading to low detection rates and an inability to provide scientifically effective OH classification. Furthermore, existing research often overlooks cerebral hemodynamic mechanisms, particularly the assessment of dynamic cerebral autoregulation (dCA), making it difficult to study the mechanisms behind OH and its associated symptoms.\n\nTo address these issues, the research team has preliminarily developed an \"Intelligent Diagnostic System for Orthostatic Hypotension\". This system innovatively integrates synchronous and continuous monitoring of multiple parameters, including non-invasive beat-to-beat blood pressure, transcranial Doppler (TCD) cerebral blood flow velocity, and electrocardiogram (ECG). It also enables the quantitative assessment of dynamic cerebral autoregulation function. The project will collaborate with fifteen high-level clinical centers in China to collect data from 2000 patients with orthostatic hypotension. The aim is to establish and externally validate a risk stratification model for OH. By integrating multimodal clinical and hemodynamic data, the investigators intend to construct an automated, precise intelligent system for the classification, subtyping, and risk stratification of OH. This initiative will establish a standardized diagnostic and management pathway covering early screening, precise classification, early warning, and stratified intervention. The goal is to provide key technological support for enhancing the early identification and standardized management of OH, thereby reducing its associated disability and mortality rates.",[66],"Orthostatic Hypotension",[66,68,69,70,71],"Blood Pressure","Cerebral Blood Flow Velocity","Cerebral Autoregulation","Risk Stratification","NOT_YET_RECRUITING","2026-01-04",{"date":75,"type":76},"2026-01-07","ACTUAL",{"date":78,"type":62},"2026-03-01",{"date":80,"type":62},"2029-02-01",{"name":5,"class":6},1]